Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-12-04
1988-06-07
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
A61K 3702
Patent
active
047496860
ABSTRACT:
This invention relates to combinations and methods for the treatment of renal disease, cardiovascular disease and hypertension. More particularly, the invention relates to combinations of renal vasodilators and .alpha..sub.1 -adrenergic or ganglionic blocking agents. According to a preferred embodiment, atriopeptins having renal vasodilator activity are used in combination with .alpha..sub.1 -adrenergic blocking agents for treating renal disease, cardiovascular disease and hypertension. The blocking agent promotes sustained renal vasodilation, thereby enhancing renal blood flow and kidney function.
REFERENCES:
Chem. Abstr. vol. 71, (1969) 69158.
Chem. Abstr. vol. 103 (1985) 64636.
Chem. Abstr. vol. 106 (1987) 60959.
Chem. Abstr. vol. 105 (1986) 209252.
Chem. Abstr. vol. 104, (1986) 82397.
Chem. Abstr. vol. 103 (1985) 87727.
Chem. Abstr. vol. 99, (1983) 191046.
Martone Patricia A.
New York Medical College
Phillips Delbert R.
LandOfFree
Combinations of renal vasodilators and .alpha..sub.1 -adrenergic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combinations of renal vasodilators and .alpha..sub.1 -adrenergic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations of renal vasodilators and .alpha..sub.1 -adrenergic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-844912